Additionally, research published in Drug Testing and Analysis characterizing AOD9604 metabolism and confirming its C-terminal HGH fragment structure, supporting its classification as a non-IGF-1-stimulating lipolytic agent has been used by clinicians evaluating the compound for metabolic applications
Maternal requirements for vitamin B12 increase during pregnancy
Other benefits include: Enhanced fat metabolism: Aids in breaking down and clearing fat from the liver and body
PubMed Cox, H.D., Smeal, S.J., Hughes, C.M., Cox, J.E., & Eichner, D
As of February 2026, no human clinical trials have been registered for 5-Amino-1MQ, and the compound remains classified as an investigational research chemical